PDF(Pubmed)
Abstract：
UNASSIGNED: The aim of this study was to evaluate the safety and efficacy of microdebrider adenoidectomy on sleep-disordered breathing among pediatric patients with OSA.
UNASSIGNED: In the microdebrider group (Group I), there were 30 Japanese OSA patients consisting of 26 boys and 4 girls. For comparison, we had 15 children (13 boys and 2 girls) who underwent classical adenoidectomy (Group II). Patients in Group I were selected from a pool of 95 pediatric Japanese OSA patients and were matched by age, preoperative AHI, and Kaup index with those in Group II.Parameters such as the amount of residual adenoid tissue, bleeding, duration of the procedure, and sleep-related metrics were compared between the two groups.
UNASSIGNED: A significant improvement in postoperative AHI was observed in Group I (p<0.05). The prevalence of AHI <1 was significantly higher in Group I compared with Group II (p<0.05). Additionally, the amount of postoperative residual adenoid was significantly less in Group I (3/30 of Grade 3 and 4 adenoid size) than in Group II (7/15, p<0.05). Furthermore, a reduction in postoperative AHI was proportionally associated with a decrease in residual adenoid.
UNASSIGNED: The newly developed microdebrider adenoidectomy technique for pediatric OSA patients with adenotonsillar hypertrophy demonstrated greater accuracy and efficacy in ameliorating sleep apnea symptoms compared with the standard adenoidectomy approach.
UNASSIGNED: In the microdebrider group (Group I), there were 30 Japanese OSA patients consisting of 26 boys and 4 girls. For comparison, we had 15 children (13 boys and 2 girls) who underwent classical adenoidectomy (Group II). Patients in Group I were selected from a pool of 95 pediatric Japanese OSA patients and were matched by age, preoperative AHI, and Kaup index with those in Group II.Parameters such as the amount of residual adenoid tissue, bleeding, duration of the procedure, and sleep-related metrics were compared between the two groups.
UNASSIGNED: A significant improvement in postoperative AHI was observed in Group I (p<0.05). The prevalence of AHI <1 was significantly higher in Group I compared with Group II (p<0.05). Additionally, the amount of postoperative residual adenoid was significantly less in Group I (3/30 of Grade 3 and 4 adenoid size) than in Group II (7/15, p<0.05). Furthermore, a reduction in postoperative AHI was proportionally associated with a decrease in residual adenoid.
UNASSIGNED: The newly developed microdebrider adenoidectomy technique for pediatric OSA patients with adenotonsillar hypertrophy demonstrated greater accuracy and efficacy in ameliorating sleep apnea symptoms compared with the standard adenoidectomy approach.
摘要：
■这项研究的目的是评估微清创腺样体切除术对OSA儿科患者睡眠呼吸紊乱的安全性和有效性。
■在微型清创器组（I组）中，有30名日本OSA患者，包括26名男孩和4名女孩。为了比较，我们有15名儿童(13名男孩和2名女孩)接受了经典腺样体切除术(II组).I组患者从95名日本儿童OSA患者中选择，并按年龄进行匹配。术前AHI,和Kaup指数与第二组的指数。参数，如残余腺样体组织的数量，出血,程序的持续时间，并比较两组的睡眠相关指标.
■在I组中观察到术后AHI的显着改善（p<0.05）。与II组相比，I组AHI<1的患病率明显更高（p<0.05）。此外,术后残余腺样体数量在I组(3/303级和4级腺样体大小)明显少于II组(7/15,p<0.05).此外，术后AHI减少与残余腺样体减少成比例相关.
■与标准腺样体切除术方法相比，新开发的用于患有腺扁桃体肥大的儿童OSA患者的微清创腺样体切除术技术在改善睡眠呼吸暂停症状方面具有更高的准确性和有效性。
■在微型清创器组（I组）中，有30名日本OSA患者，包括26名男孩和4名女孩。为了比较，我们有15名儿童(13名男孩和2名女孩)接受了经典腺样体切除术(II组).I组患者从95名日本儿童OSA患者中选择，并按年龄进行匹配。术前AHI,和Kaup指数与第二组的指数。参数，如残余腺样体组织的数量，出血,程序的持续时间，并比较两组的睡眠相关指标.
■在I组中观察到术后AHI的显着改善（p<0.05）。与II组相比，I组AHI<1的患病率明显更高（p<0.05）。此外,术后残余腺样体数量在I组(3/303级和4级腺样体大小)明显少于II组(7/15,p<0.05).此外，术后AHI减少与残余腺样体减少成比例相关.
■与标准腺样体切除术方法相比，新开发的用于患有腺扁桃体肥大的儿童OSA患者的微清创腺样体切除术技术在改善睡眠呼吸暂停症状方面具有更高的准确性和有效性。
